We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Apiam Animal Health Limited is a personal services business based in Australia. Apiam Animal Health shares (AHX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Apiam Animal Health has a trailing 12-month revenue of around $126.2 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.5546 - $1 |
|---|---|
| 50-day moving average | $0.9499 |
| 200-day moving average | $0.903 |
| Target price | $1.25 |
| PE ratio | 23.2143 |
| Dividend yield | $0.024 (2.42%) |
| Earnings per share (TTM) | $0.042 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.975
| 1 week (2021-09-16) | -2.50% |
|---|---|
| 1 month (2021-08-26) | 5.98% |
| 3 months (2021-06-25) | 2.63% |
| 6 months (2021-03-26) | 26.62% |
| 1 year (2020-09-24) | 52.34% |
|---|---|
| 2 years (2019-09-26) | 103.13% |
| 3 years (2018-09-26) | 83.96% |
| 5 years (2016-09-26) | -40.91% |
Valuing Apiam Animal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Apiam Animal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Apiam Animal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Apiam Animal Health shares trade at around 23x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Apiam Animal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11.7 million (£0.0 million).
The EBITDA is a measure of a Apiam Animal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $126.2 million |
|---|---|
| Operating margin TTM | 6.56% |
| Gross profit TTM | $25.3 million |
| Return on assets TTM | 3.47% |
| Return on equity TTM | 6.69% |
| Profit margin | 4.03% |
| Book value | 0.597 |
| Market capitalisation | $131.3 million |
TTM: trailing 12 months
Dividend payout ratio: 60% of net profits
Recently Apiam Animal Health has paid out, on average, around 60% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.42% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Apiam Animal Health shareholders could enjoy a 2.42% return on their shares, in the form of dividend payments. In Apiam Animal Health's case, that would currently equate to about A$0.024 per share.
Apiam Animal Health's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 15 September 2021 (the "ex-dividend date").
Over the last 12 months, Apiam Animal Health's shares have ranged in value from as little as $0.5546 up to $1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Apiam Animal Health's is 0.5177. This would suggest that Apiam Animal Health's shares are less volatile than average (for this exchange).
Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals in Australia. The company operates through three segments: Dairy and Mixed, Feedlots, and Pigs. It engages in the provision of veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services. The company offers companion animal, dairy, swine and poultry, beef feedlot, equine, sheep, and genetic services. It also provides telemedicine, remote video headgear, health management apps for production animals systems, benchmarking databases, and herd management software. The company offers general animal health products through eCommerce. It provides its services through animal veterinary clinics. Apiam Animal Health Limited was founded in 1998 and is based in Bendigo, Australia.
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
We look at some of the biggest and best performing iron ore stocks in Australia.
Shares in the major banks have risen more than 50% in the last 12 months.
Steps to owning and managing China Evergrande Group shares from Australia.
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
